DNA Funded vs Topstep

Side-by-side comparison of trust scores, profit splits, payout speed, and real trader reviews. Independent data — no sponsored rankings.

DNA FUNDED DETAILS

+No performance data is available to identify any above-average metrics for this firm
+No fee, payout, or structure data provided to evaluate competitiveness
+No platform or market data available to assess trading flexibility
+Country of operation (Australia) is noted, but no regulatory or structural data exists

−No data is provided for this firm, making any meaningful comparison impossible
−Traders cannot assess profit split, funding, or costs against the 84.7% and $186.7 averages
−Complete absence of data is a significant transparency concern for traders making financial decisions

+Profit split of 90% is well above the industry average of 84.7%, offering traders a superior earnings share.
+Min challenge cost of $49 is well below the industry average of $186.7, making entry highly accessible.
+Single-step funding is better than the industry average of 1.6 steps, streamlining the path to funded status.
+Founded in 2012, Topstep is one of the most established prop firms, providing strong credibility and track record.

−Max funding of $150,000 is far below the industry average of $839,272.7, significantly limiting earning potential.
−Overall drawdown of 10% with trailing EOD type means drawdown limits tighten as profits grow, increasing risk.
−Days to first payout at 7 is slightly above the industry average of 6.5, a minor but notable delay.

DNA Funded

Not yet rated by PropDNA traders. Slower payouts at —d.

Topstep

Trust score 69/100. Faster payouts at 7d. 90% profit split.